Eyenuk Inc.’s AI-based diabetic retinopathy screening software EyeArt™ tested with portable smartphone-based imaging device in new study indicating potential for highly sensitive yet cost-effective mass retinal screening
A new study published in the international ‘Eye’ journal (Springer Nature) demonstrated very high sensitivity for detecting any diabetic retinopathy (95.8%) and sight-threatening diabetic retinopathy (99.1%) using EyeArt™ automated screening software with Remidio Fundus …